These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33223029)
41. Surgery for Glioblastoma in Elderly Patients. Conti Nibali M; Gay LG; Sciortino T; Rossi M; Caroli M; Bello L; Riva M Neurosurg Clin N Am; 2021 Jan; 32(1):137-148. PubMed ID: 33223022 [TBL] [Abstract][Full Text] [Related]
42. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous. Drapeau A; Fortin D Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730 [TBL] [Abstract][Full Text] [Related]
43. Recent advances in brain tumor therapy: application of electrospun nanofibers. Norouzi M Drug Discov Today; 2018 Apr; 23(4):912-919. PubMed ID: 29499377 [TBL] [Abstract][Full Text] [Related]
44. Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies. Karlsson J; Luly KM; Tzeng SY; Green JJ Adv Drug Deliv Rev; 2021 Dec; 179():113999. PubMed ID: 34715258 [TBL] [Abstract][Full Text] [Related]
45. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Ganipineni LP; Danhier F; Préat V J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958 [TBL] [Abstract][Full Text] [Related]
46. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Koukourakis MI; Koukouraki S; Fezoulidis I; Kelekis N; Kyrias G; Archimandritis S; Karkavitsas N Br J Cancer; 2000 Nov; 83(10):1281-6. PubMed ID: 11044350 [TBL] [Abstract][Full Text] [Related]
47. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine. Kim SS; Harford JB; Pirollo KF; Chang EH Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770 [TBL] [Abstract][Full Text] [Related]
48. Designing Next-Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic. Tabet A; Jensen MP; Parkins CC; Patil PG; Watts C; Scherman OA Adv Healthc Mater; 2019 Feb; 8(3):e1801391. PubMed ID: 30632715 [TBL] [Abstract][Full Text] [Related]
49. Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma. Huang WC; Lu IL; Chiang WH; Lin YW; Tsai YC; Chen HH; Chang CW; Chiang CS; Chiu HC J Control Release; 2017 May; 254():119-130. PubMed ID: 28336375 [TBL] [Abstract][Full Text] [Related]
50. Endovascular therapies for malignant gliomas: Challenges and the future. Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294 [TBL] [Abstract][Full Text] [Related]
51. Current therapeutic paradigms in glioblastoma. Quick A; Patel D; Hadziahmetovic M; Chakravarti A; Mehta M Rev Recent Clin Trials; 2010 Jan; 5(1):14-27. PubMed ID: 20205684 [TBL] [Abstract][Full Text] [Related]
52. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach. Agarwal S; Muniyandi P; Maekawa T; Kumar DS Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647 [TBL] [Abstract][Full Text] [Related]
53. Fabrication and characterization of implantable flushable electrodes for electric field-mediated drug delivery in a brain tissue-mimic agarose gel. Parupudi T; Rahimi R; Ammirati M; Sundararajan R; Garner AL; Ziaie B Electrophoresis; 2018 Sep; 39(17):2262-2269. PubMed ID: 29947027 [TBL] [Abstract][Full Text] [Related]
54. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598 [TBL] [Abstract][Full Text] [Related]
55. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126 [TBL] [Abstract][Full Text] [Related]
56. Convection-enhanced delivery for the treatment of glioblastoma. Vogelbaum MA; Aghi MK Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090 [TBL] [Abstract][Full Text] [Related]
57. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection. Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360 [TBL] [Abstract][Full Text] [Related]
58. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma. Dréan A; Goldwirt L; Verreault M; Canney M; Schmitt C; Guehennec J; Delattre JY; Carpentier A; Idbaih A Expert Rev Neurother; 2016 Nov; 16(11):1285-1300. PubMed ID: 27310463 [TBL] [Abstract][Full Text] [Related]
59. Rationally designed drug delivery systems for the local treatment of resected glioblastoma. Bastiancich C; Malfanti A; Préat V; Rahman R Adv Drug Deliv Rev; 2021 Oct; 177():113951. PubMed ID: 34461201 [TBL] [Abstract][Full Text] [Related]
60. Standard therapy for glioblastoma--a review of where we are. Nishikawa R Neurol Med Chir (Tokyo); 2010; 50(9):713-9. PubMed ID: 20885105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]